WASHINGTON -- A marketing campaign for a GlaxoSmithKline prostate drug has drawn complaints from federal regulators, who said the space-themed advertisement is misleading. The British drugmaker's ...
Full results of a big study testing a drug for preventing prostate cancer show a higher risk of heart failure, a surprise finding that could dampen enthusiasm for expanding its use. On Monday, ...
Even as snow socked Washington, the Food and Drug Administration managed to get a letter to GlaxoSmithKline rejecting the company's proposal to sell the pill Avodart as a way to reduce the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback